Hospice M&A Valuations Ticking Upward

Why It Matters

The upward shift in hospice valuations signals renewed investor confidence and could accelerate consolidation in a fragmented market. Aligning expectations and addressing compliance risks will be critical for firms seeking growth through acquisitions.

Key Takeaways

• Hospice deal volume rose to 16 transactions in Q4 2025.
• Multiples are climbing as interest rates fall and platform deals pay premiums.
• Large platform transactions create valuation spillover to mid‑market deals.
• Buyer‑seller valuation gaps narrowing after 2022‑24 decline.
• Compliance audits essential; regulatory risk may block deals in several states.

Pulse Analysis

The hospice sector has long been characterized by a patchwork of small operators and modest transaction activity. After a three‑year decline, the market showed a clear inflection point in late 2025, with the fourth quarter recording 16 acquisitions—the strongest pace since the post‑pandemic peak of 2021. Lower federal interest rates have reduced financing costs, making debt‑backed deals more attractive and prompting buyers to re‑evaluate pricing models that had been compressed during the rate‑hike cycle.

At the heart of the valuation uplift are a handful of high‑profile platform deals that paid premium multiples for strategic scale. Transactions such as Linden Capital Partners’ purchase of Agape Care Group and The Pennant Group’s $146 million acquisition of hospice and home‑health assets have set new benchmarks. These deals generate a “trickle‑down” effect, lifting comparable multiples for lower‑ and middle‑market operators and compressing the valuation gap that widened between buyers and sellers from 2022 through 2024. As expectations converge, sellers are more willing to accept market‑based offers, while buyers gain confidence that price signals reflect sustainable cash‑flow prospects.

Regulatory scrutiny now looms as a decisive factor in deal execution. States like California, Arizona, Nevada, Texas, Georgia and Ohio have intensified compliance oversight, raising the risk of clawbacks or billing disputes that can derail a transaction. Industry participants are advised to conduct thorough compliance and billing audits before entering the market, quantifying potential liabilities and ensuring alignment with state‑specific regulations. Firms that proactively address these risks will be better positioned to capture value in an accelerating consolidation wave, while those that overlook compliance may see deals stall or collapse.